Quantcast

Latest Tumors Stories

2015-01-16 08:25:19

First-in-Class Agent is Well Tolerated in Liver Cancer Patients SAN ANTONIO, Jan.

2015-01-06 08:31:37

Study to focus on mutations and deletions of CREBBP and EP300 genes in lymphomas SAN DIEGO, Jan. 6, 2015 /PRNewswire/ -- Mirati Therapeutics, Inc.

3D liver
2014-12-31 12:05:28

Researchers from the Karlsruhe Institute of Technology (KIT) have developed a computation method capable of adapting a non-deformed model to the underlying deformed surface profile of an organ during minimally invasive surgical procedures.

2014-12-23 08:25:15

Study Seeks to Confirm a High Response Rate among Cancer Patients with MET and Axl Genetic Alterations SAN DIEGO, Dec. 23, 2014 /PRNewswire/ -- Mirati Therapeutics, Inc.

2014-12-08 04:22:21

GOSSELIES, Belgium, Dec. 8, 2014 /PRNewswire/ -- iTeos Therapeutics SA announced today a strategic collaboration with Pfizer Inc.

2014-09-15 23:11:36

A collaborative study between researchers at the University of Colorado Cancer Center and the National Cancer Institute (NCI) published today in the journal Clinical Cancer Research takes an important


Word of the Day
dwale
  • The deadly nightshade, Atropa Belladonna, which possesses stupefying or poisonous properties.
  • A sleeping-potion; a soporific.
  • To mutter deliriously.
The word 'dwale' comes from an Old English word meaning 'error, doubt, delusion.'
Related